chr20-62819981-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001853.4(COL9A3):​c.308G>A​(p.Arg103Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 1,612,462 control chromosomes in the GnomAD database, including 279 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R103W) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0096 ( 16 hom., cov: 33)
Exomes 𝑓: 0.015 ( 263 hom. )

Consequence

COL9A3
NM_001853.4 missense, splice_region

Scores

3
15
Splicing: ADA: 0.004469
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.98

Publications

16 publications found
Variant links:
Genes affected
COL9A3 (HGNC:2219): (collagen type IX alpha 3 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]
COL9A3 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen
  • Stickler syndrome, type 6
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0064404905).
BP6
Variant 20-62819981-G-A is Benign according to our data. Variant chr20-62819981-G-A is described in ClinVar as Benign. ClinVar VariationId is 197734.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00963 (1463/151968) while in subpopulation SAS AF = 0.0439 (211/4810). AF 95% confidence interval is 0.039. There are 16 homozygotes in GnomAd4. There are 681 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A3NM_001853.4 linkc.308G>A p.Arg103Gln missense_variant, splice_region_variant Exon 5 of 32 ENST00000649368.1 NP_001844.3 Q14050

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A3ENST00000649368.1 linkc.308G>A p.Arg103Gln missense_variant, splice_region_variant Exon 5 of 32 NM_001853.4 ENSP00000496793.1 Q14050
COL9A3ENST00000452372.2 linkc.197G>A p.Arg66Gln missense_variant, splice_region_variant Exon 4 of 12 5 ENSP00000394280.1 Q4VXW1
COL9A3ENST00000477612.5 linkn.304G>A splice_region_variant, non_coding_transcript_exon_variant Exon 5 of 12 3
COL9A3ENST00000489045.5 linkn.354G>A splice_region_variant, non_coding_transcript_exon_variant Exon 4 of 14 5

Frequencies

GnomAD3 genomes
AF:
0.00965
AC:
1465
AN:
151850
Hom.:
16
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.0229
Gnomad SAS
AF:
0.0442
Gnomad FIN
AF:
0.00226
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.0137
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.0136
AC:
3395
AN:
249638
AF XY:
0.0155
show subpopulations
Gnomad AFR exome
AF:
0.00149
Gnomad AMR exome
AF:
0.00269
Gnomad ASJ exome
AF:
0.00219
Gnomad EAS exome
AF:
0.0215
Gnomad FIN exome
AF:
0.00228
Gnomad NFE exome
AF:
0.0129
Gnomad OTH exome
AF:
0.00753
GnomAD4 exome
AF:
0.0150
AC:
21913
AN:
1460494
Hom.:
263
Cov.:
33
AF XY:
0.0158
AC XY:
11485
AN XY:
726570
show subpopulations
African (AFR)
AF:
0.00191
AC:
64
AN:
33480
American (AMR)
AF:
0.00271
AC:
121
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00295
AC:
77
AN:
26136
East Asian (EAS)
AF:
0.0188
AC:
747
AN:
39696
South Asian (SAS)
AF:
0.0417
AC:
3601
AN:
86256
European-Finnish (FIN)
AF:
0.00309
AC:
161
AN:
52130
Middle Eastern (MID)
AF:
0.0135
AC:
78
AN:
5764
European-Non Finnish (NFE)
AF:
0.0147
AC:
16339
AN:
1111942
Other (OTH)
AF:
0.0120
AC:
725
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
1247
2494
3742
4989
6236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00963
AC:
1463
AN:
151968
Hom.:
16
Cov.:
33
AF XY:
0.00917
AC XY:
681
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.00256
AC:
106
AN:
41480
American (AMR)
AF:
0.00288
AC:
44
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3470
East Asian (EAS)
AF:
0.0232
AC:
118
AN:
5090
South Asian (SAS)
AF:
0.0439
AC:
211
AN:
4810
European-Finnish (FIN)
AF:
0.00226
AC:
24
AN:
10598
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.0137
AC:
930
AN:
67930
Other (OTH)
AF:
0.00520
AC:
11
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
77
155
232
310
387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0130
Hom.:
33
Bravo
AF:
0.00826
TwinsUK
AF:
0.0151
AC:
56
ALSPAC
AF:
0.0176
AC:
68
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.0133
AC:
114
ExAC
AF:
0.0145
AC:
1756
Asia WGS
AF:
0.0290
AC:
101
AN:
3478
EpiCase
AF:
0.0119
EpiControl
AF:
0.0129

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30467950) -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COL9A3: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 07, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 06, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Connective tissue disorder Benign:1
Mar 05, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
T;T;.
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.79
.;T;T
MetaRNN
Benign
0.0064
T;T;T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Benign
0.51
N;N;.
PhyloP100
2.0
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.21
.;N;N
REVEL
Benign
0.16
Sift
Benign
0.22
.;T;T
Sift4G
Benign
0.13
.;T;T
Polyphen
0.022
B;B;.
Vest4
0.11
MPC
0.081
ClinPred
0.013
T
GERP RS
3.7
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
3.1
Varity_R
0.079
gMVP
0.50
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0045
dbscSNV1_RF
Benign
0.15
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142639450; hg19: chr20-61451333; COSMIC: COSV59650202; COSMIC: COSV59650202; API